Related Experiment Videos
Dispermic chimera associated with dysgerminoma
H Takizawa1, I Nakamura, Y Hirasawa
1Department of Legal Medicine, Faculty of Medicine, Toyama Medical and Pharmaceutical University, Japan.
Experimental and Clinical Immunogenetics
|January 1, 1989
Summary
This study investigates a rare case of a 12-year-old patient with an abdominal tumor, revealing she is a generalized chimera with both male (XY) and female (XX) cell lines. This condition contributed to the tumor
Area of Science:
- Human genetics and developmental biology
- Reproductive medicine and oncology
Background:
- Chimerism, a rare condition where an individual possesses two or more genetically distinct cell lines, can arise from dispermic fusion or other developmental anomalies.
- Understanding chimerism is crucial for diagnosing complex genetic conditions and their associated health risks, including malignancies.
Observation:
- A 12-year-old female patient presented with an abdominal tumor and was diagnosed as a dispermic chimera.
- Blood analysis revealed distinct cell populations: 92% group A1 (XY) and 8% group B (XX), with specific PGM1 and PGD phenotypes.
- Buccal mucosa cells showed a mix of A and B antigens, with an atypical ratio of X-chromatin and Y-body positive cells.
Findings:
- The patient's cells originated from two distinct lines: one 46 XY male line carrying the A1 gene and one 46 XX female line carrying the B gene.
- The abdominal tumor, a dysgerminoma, showed tumor cells expressing A antigen and blood vessel endothelial cells expressing B antigen.
- The patient's hair roots exhibited a 1A-2A PGM1 phenotype and were Y-body negative, while nails showed potent B antigen expression.
Implications:
- The findings suggest the patient's right gonad, derived from the XY cell line, developed a malignancy in the presence of the Y chromosome.
- This case highlights the complex interplay between genetic makeup, gonadal development, and oncogenesis in chimeras.
- Further research into chimerism can improve diagnostic approaches and therapeutic strategies for related genetic and oncological conditions.